Corrigendum: Cuproptosis key gene FDX1 is a prognostic biomarker and associated with immune infiltration in glioma

Hanwen Lu^#^{1

2}, Liwei Zhou^#^{1

3}, Bingchang Zhang^{1

3}, Yuanyuan Xie^{1

3}, Huiyin Yang^{1

2}, Zhanxiang Wang^{1

2

3}

Affiliations

¹ Department of Neurosurgery, Xiamen Key Laboratory of Brain Center, The First Affiliated Hospital of Xiamen University, School of Medicine, Xiamen University, Xiamen, China.
² Department of Neuroscience, Institute of Neurosurgery, School of Medicine, Xiamen University, Xiamen, China.
³ Department of Neurosurgery, The First Affiliated Hospital of Xiamen University, School of Medicine, Xiamen University, Xiamen, China.

^# Contributed equally.

Published Erratum

Hanwen Lu et al. Front Med (Lausanne). 2023.

. 2023 Jul 10:10:1244638.

doi: 10.3389/fmed.2023.1244638. eCollection 2023.

Hanwen Lu^#^{1

2}, Liwei Zhou^#^{1

3}, Bingchang Zhang^{1

3}, Yuanyuan Xie^{1

3}, Huiyin Yang^{1

2}, Zhanxiang Wang^{1

2

3}

¹ Department of Neurosurgery, Xiamen Key Laboratory of Brain Center, The First Affiliated Hospital of Xiamen University, School of Medicine, Xiamen University, Xiamen, China.
² Department of Neuroscience, Institute of Neurosurgery, School of Medicine, Xiamen University, Xiamen, China.
³ Department of Neurosurgery, The First Affiliated Hospital of Xiamen University, School of Medicine, Xiamen University, Xiamen, China.

^# Contributed equally.

Abstract

[This corrects the article DOI: 10.3389/fmed.2022.939776.].

Keywords: Cuproptosis; glioma; immune infiltration; lipoylation; prognostic biomarker.

Cuproptosis key gene FDX1 is a prognostic biomarker and associated with immune infiltration in glioma.
Lu H, Zhou L, Zhang B, Xie Y, Yang H, Wang Z. Lu H, et al. Front Med (Lausanne). 2022 Nov 29;9:939776. doi: 10.3389/fmed.2022.939776. eCollection 2022. Front Med (Lausanne). 2022. PMID: 36523779 Free PMC article.